Skip to main content
Device/Product Name
Zyamis
Active ingredients
Midazolam maleate
AusPAR Date
Published
Submission Number
PM- 2020-04183-1-1
Submission Type
Extension of indications (new indication with a new route of administration for a new salt of a registered active ingredient)
Decision
Approved

Help us improve the Therapeutic Goods Administration site